Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease

Aims: Atherosclerotic cardiovascular disease (ASCVD) risk is increased in patients with Inflammatory Bowel Disease (IBD). The impact of advanced biologic therapies (ABT) on ASCVD risk in patients with IBD has not been reported. This study tests the hypothesis of a protective effect of immune modulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Lara Chaaban, Tarek Harb, Gary Gerstenblith, Thorsten M. Leucker, Joanna Melia
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:American Journal of Preventive Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667725000662
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items